Fl color promo padding top px. Font family Tahoma, Lucida Grande, sans serif. FDA clears cum shot new rotavirus vaccine. WASHINGTON A second oral vaccine to prevent a leading cause of severe diarrhea in infants won approval from U. The GlaxoSmithKline vaccine Rotarix fights infection with the rotavirus, which causes about, hospitalizations in U.

The vaccine competes with Merck’s rotavirus vaccine called RotaTeq.

The most common Blogroll reported during clinical trials were fussiness, irritability, cough, runny nose, fever, loss of appetite and vomiting, the FDA said.

An earlier oral rotavirus vaccine sold by Wyeth was pulled from the market in after it was linked to a rare, life 1998 1999 burundi country review type of bowel obstruction known as intussusception. Merck’s RotaTeq vaccine is administered in three doses from ages six weeks to weeks.

Sales of Rotarix were million in and are expected to rise with approval in the large U. The vaccine will be commercially available in the United States in the second half of the year, Glaxo said. The Glaxo funded trial of more than, infants found severe diarrhea from rotavirus in. The arrival of a new generation of oral vaccines against the disease has been welcomed by health care workers, but some experts caution against assuming the vaccines will work equally well in all countries. In a commentary in the Lancet, Biological source of erythromycin pediatric experts Keith Grimwood and Carl Kirkwood noted Rotarix was more effective in European trials than in middle income Latin American countries. Risk of bird flu pandemic growing, officials say.

Children in Keira now have deadly virus.

Chronic Lyme disease Docs may change stance. Records offer 2005 nec code book into polygamist families.

Congressman admits fathering child from affair.

Bone marrow treatments repair MS patients.

.

What Everybody Ought to Know About cheap drugs.